Navigation Links
Therapure Biopharma Inc. signs fill/finish contract with Kane Biotech Inc.
Date:3/29/2010

Therapure will provide fill/finish services to support product development.

Toronto, ON (Vocus) March 29, 2010 -- Therapure Biopharma Inc. today announced a fill/finish contract with Kane Biotech Inc. (V.KNE), a Canadian biotechnology company based in Winnipeg, Manitoba. Under the terms of the agreement, Therapure will provide custom fill/finish services for a key development-stage product for Kane Biotech. Financial terms were not disclosed.

Kane Biotech is a biotechnology company engaged in the development of products to prevent and disperse biofilms. Biofilms are a major cause of a number of serious medical problems including chronic infections and medical device related infections. Biofilms develop on surfaces such as catheters, prosthetic implants, teeth, lungs and the urogenital tract. Biofilms are pervasive, costly to deal with and approximately 80% of all human bacterial infections involve biofilms. The healing of chronic wounds alone costs the US health care system $20 billion per year.

“Therapure has signed a variety of fill/finish contracts recently, demonstrating the flexibility of our Health Canada licensed facility” said Thomas Wellner, President and CEO of Therapure. "Our agreement with Kane Biotech includes hand-fill services conducted under Good Manufacturing Practices standards," continued Mr. Wellner.

"Therapure was quick to provide a detailed service proposal that clearly indicated they understood our requirements," said Gord Froehlich, President and CEO of Kane. "We look forward to working closely with Therapure as we advance out products through the approval process," Mr. Froehlich concluded.

About Therapure Biopharma Inc.:
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market for its clients. Therapure’s Health Canada licensed 130,000 sq. ft. facility, includes manufacturing, research and quality control laboratories and a cGMP warehouse, and is built to U.S. FDA, EMEA, MHRA and Health Canada standards for the aseptic handling and purification of proteins.

For more information, please visit: www.therapurebio.com

Company Contact:
Thomas Wellner, President and CEO
Therapure Biopharma Inc.
+1 905 286-6204
ceo (at) therapurebio (dot) com

###

Read the full story at http://www.prweb.com/releases/ContractManufacture/FillFinish/prweb3796474.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Therapure Biopharma Inc. signs multi-year manufacturing agreement with LFB Biomedicaments
2. Therapure Biopharma Inc. Commissions its Commercial-Scale Lyophilizer
3. Microbix and Therapure Biopharma Form Partnership to Expand Water-Based Supplies to the Pharma Industry
4. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
5. Therapure Biopharma Inc. and Akorn, Inc. Announce Strategic Supply Contract
6. PDL BioPharma Announces Two $0.50 Dividends in 2010
7. Seven More Biopharmaceutical Research Companies Join PhRMA
8. BioProcess International Launches a New and Improved Website for Biopharmaceutical Managers and Scientists
9. Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009
10. New Polycarbonate Sign Face Material Eliminates Hot Spots, Optimizes Light Uniformity in LED Back-Lit Signs
11. President Signs Health Reform Bill that Aids Small Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 26, 2016 , ... There are many ways to cook a hot dog, ... that Americans prefer their dogs straight off the grill. Of the 90 percent of ... way to cook a hot dog, far outpacing other cooking methods such as steaming ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, ... defective respirators, according to court documents and SEC filings. A jury has ... Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The ...
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State ... its specialty academic programs. , Answering to the increasing demand for curricular specializations, ... health law, and environmental and land use law. ,  , “The demand for ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For Heroes ... lives in military battle for the country. The nonprofit Hope For Heroes partnered ... programs that empower independence for disabled military veterans, as well as police, firemen, and ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac ... significant negative impact on long-term patient survival, reports a team of UPMC researchers ... this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland , ... QGEN ; Frankfurt Prime Standard: QIA) today announced ... agreement with Therawis Diagnostics GmbH to develop and commercialize predictive ... and market PITX2 as a marker to predict effectiveness of ... patients. "We are pleased to partner with Therawis, ...
(Date:5/25/2016)... , May 25, 2016 As ... Expo earlier this month, the numbers and momentum of ... to climb into the billions, more research and development ... 4th Edition State of Legal Marijuana Markets Report  from ... data-analysis firm, much of the increase in sector is ...
(Date:5/25/2016)... Inivata, a global clinical ... tumour DNA (ctDNA) analysis to improve personalised healthcare ... Clive Morris as Chief Medical Officer. ... development programme, scientific collaborations, and through to commercialisation ... in clinical outcomes for patients. Clive ...
Breaking Medicine Technology: